Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
Stephen I. Sadove, a director of Aramark (ARMK), reported an internal transaction dated 08/20/2025 showing acquisition of 210.525 dividend-equivalent rights related to deferred stock units at a $0 price. After the transaction he beneficially owned 94,042.121 shares directly and 15,000 shares indirectly through a trust. The filing explains these dividend-equivalent rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Susan M. Cameron, a director of Aramark (ARMK), reported a non‑derivative acquisition of 111.956 shares on 08/20/2025. The filing states these shares represent dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. The reported per‑share price is $0, and following the transaction the reporting person beneficially owns 42,825.523 shares. The Form 4 was signed by an attorney‑in‑fact on 08/21/2025.
Brian M. DelGhiaccio, a director of Aramark (ARMK), reports a small acquisition tied to dividend-equivalent rights. The reporting person was credited with 29.129 shares as dividend equivalents on deferred stock units that vest on the same schedule as the underlying awards, and the transaction is recorded as an acquisition at no cash cost. After the credit, the reporting person beneficially owns 11,142.312 shares. The reported transaction date is 08/20/2025. The Form 4 shows this filing was submitted by an attorney-in-fact on behalf of the reporting person.
Richard W. Dreiling, a director of Aramark (ARMK), received dividend-equivalent rights that converted to 18.645 shares on 08/20/2025 at no cost to him. After the transaction he beneficially owned 6,267.292 shares. The filing states these dividend-equivalent rights accrued on deferred stock units and vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Aramark (ARMK) director Kenneth M. Keverian received dividend-equivalent rights tied to deferred stock units on 08/20/2025. The filing reports an acquisition (code A) of 62.2 dividend-equivalent units at a reported price of $0, and shows 23,792.883 shares beneficially owned following the transaction. The dividend-equivalent rights vest on the same schedule as the underlying deferred stock units. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/21/2025.
Aramark disclosed Amendment No. 18 to its Credit Agreement dated March 28, 2017, effected August 15, 2025, which adds U.S. Term B-9 Loans. The U.S. Term B-9 Loans bear interest either at (a) a Eurodollar-type rate plus an initial margin of 1.75% or (b) a base rate tied to the highest of the administrative agent's prime rate, the federal funds rate plus 0.50%, and Term SOFR for a one-month interest period plus 1.00%, plus an initial margin of 0.75%. The U.S. Term B-9 Loans do not require quarterly principal repayments and are subject to substantially similar guarantees, collateral, mandatory prepayments and covenants as the previously outstanding U.S. Term B-7 Loans and the company's other U.S. Term B Loans under the Credit Agreement.
Aramark (ARMK) reporting person: Marc A. Bruno, COO, U.S. Food & Facilities, completed option-related transactions on 08/14/2025. He exercised stock options with a $23.55 exercise price for 49,793 shares and, in a net exercise, disposed of 35,160 shares to cover the exercise price and tax withholding. The filings show 49,793 shares acquired via exercise and 35,160 shares sold at $39.60. Beneficial ownership moved from 259,023.226 shares after the sale to 294,183.226 shares following the acquisition entry in the filing sequence. The options exercised are fully vested and expire on 11/20/2025.
Janus Henderson Group plc filed Amendment No. 3 to Schedule 13G reporting passive ownership stakes in ARAMARK common stock. The filing identifies an aggregate beneficial ownership of 17,963,599 shares (6.9% of the class) with shared voting and dispositive power reported at 17,963,599 shares. A subsidiary (JHIUS) is separately noted as being the beneficial owner of 17,480,394 shares (6.7%) with shared voting and dispositive power matching that amount. The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
The document includes issuer and filer addresses, a power of attorney authorizing designated signatories to file required reports, and is signed by Kristin Mariani, Head of North America Compliance, CCO, dated 08/14/2025. The date triggering this filing is 06/30/2025.
Farallon-affiliated funds and related entities report passive ownership stakes in Aramark common stock under Rule 13d-1(c). Combined holdings reported by the Farallon Individual Reporting Persons total 12,899,701 shares (4.9% of the class), with Farallon Partners, L.L.C. shown with 12,647,640 shares (4.8%) and Farallon Equity Partners Master, L.P. holding 9,070,923 shares (3.5%). Other Farallon funds report smaller stakes ranging from 168,227 to 1,590,986 shares.
The filing states the shares are held directly by the funds and are reported as passive; the reporting persons certify the securities were not acquired to change or influence control. The filing also notes the reporting persons neither disclaim nor affirm the existence of a group, and that certain individuals may be deemed beneficial owners while disclaimers of beneficial ownership are included.